Cambridge Investment Research Advisors, Inc. - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 77 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2017$87,000
-73.8%
39,150
-65.8%
0.00%
-75.0%
Q3 2017$332,000
-49.9%
114,525
-23.2%
0.00%
-60.0%
Q2 2017$663,000
-10.0%
149,075
-5.7%
0.01%
-23.1%
Q1 2017$737,000
-24.2%
158,075
-0.9%
0.01%
-27.8%
Q4 2016$972,000
+8.5%
159,575
-1.8%
0.02%
+5.9%
Q3 2016$896,000
+17.9%
162,575
-18.7%
0.02%
+6.2%
Q2 2016$760,000
+24.8%
199,975
-9.4%
0.02%
+14.3%
Q1 2016$609,000
-56.7%
220,809
-11.1%
0.01%
-57.6%
Q4 2015$1,408,000
+5.8%
248,289
-1.1%
0.03%
-13.2%
Q3 2015$1,331,000
-36.4%
251,164
-0.4%
0.04%
-34.5%
Q2 2015$2,093,000
+68.0%
252,164
-6.5%
0.06%
+65.7%
Q1 2015$1,246,000
+34.6%
269,805
-11.2%
0.04%
+20.7%
Q4 2014$926,000
-15.4%
303,705
-22.7%
0.03%
-9.4%
Q3 2014$1,094,000
-36.8%
392,670
-7.6%
0.03%
-46.7%
Q2 2014$1,730,000
-26.2%
424,990
-3.7%
0.06%
-32.6%
Q1 2014$2,343,000
-9.7%
441,290
-4.2%
0.09%
-16.0%
Q4 2013$2,594,000
+26.4%
460,665
+2.6%
0.11%
+17.8%
Q3 2013$2,052,000
+27.8%
449,080
+20.8%
0.09%
+9.8%
Q2 2013$1,606,000371,8250.08%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q4 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,009,984$16,683,0006.50%
DAFNA Capital Management LLC 317,563$2,636,0002.23%
Trellus Management Company, LLC 162,900$1,352,0001.53%
PURA VIDA INVESTMENTS, LLC 246,250$2,246,0001.15%
WALL STREET ASSOCIATES 861,200$7,148,0000.67%
EAM Investors, LLC 670,346$5,564,0000.65%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 200,000$1,660,0000.58%
CARL DOMINO INC 66,900$555,0000.38%
Belmont Global Advisors, Inc. 36,200$300,0000.33%
Lombard Odier Asset Management (USA) Corp 507,223$4,210,0000.30%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders